Hikal Ltd Stock Falls to 52-Week Low of Rs.197.15 Amidst Continued Downtrend

Recent Price Movement and Market Context

On 23 Jan 2026, Hikal Ltd’s stock price touched Rs.197.15, its lowest level in the past year, down from a 52-week high of Rs.456.60. This decline reflects a broader trend of weakness, with the stock trading below all key moving averages including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. The Sensex, by contrast, opened flat and traded marginally lower at 82,130.63, down 0.21%, remaining 4.9% below its own 52-week high of 86,159.02. While the benchmark index shows some resilience, Hikal’s performance has diverged sharply.

Over the last year, Hikal Ltd has delivered a negative return of -46.18%, starkly contrasting with the Sensex’s positive 7.29% gain over the same period. This underperformance extends beyond the last 12 months, with the stock also lagging the BSE500 index across one year, three years, and the recent three-month period.

Financial Performance and Fundamental Metrics

Hikal Ltd’s financial indicators reveal challenges that have contributed to the stock’s decline. The company’s operating profits have contracted at a compound annual growth rate (CAGR) of -16.24% over the past five years, signalling weakening earnings power. The latest quarterly results, declared in September 2025, were notably adverse, with earnings per share (EPS) falling by 320.54% compared to the previous four-quarter average.

Net sales for the quarter stood at Rs.318.50 crore, down 30.5% from the preceding four-quarter average, while the net profit after tax (PAT) recorded a loss of Rs.34.90 crore, a 320.5% decline. Return on capital employed (ROCE) for the half-year was reported at a low 4.44%, underscoring subdued capital efficiency. The average return on equity (ROE) remains modest at 8.00%, indicating limited profitability relative to shareholders’ funds.

Debt metrics also raise concerns, with a debt-to-EBITDA ratio of 2.51 times, reflecting a relatively high leverage position that may constrain financial flexibility. Despite these challenges, the stock’s valuation metrics suggest some degree of market discounting, with an enterprise value to capital employed ratio of 1.7, which is lower than peer averages.

Stock Rating and Market Sentiment

Reflecting the company’s financial trajectory, Hikal Ltd’s Mojo Score currently stands at 12.0, with a Mojo Grade of Strong Sell as of 14 Nov 2025, an upgrade from the previous Sell rating. This grading is influenced by the company’s weak long-term fundamentals, deteriorating profitability, and recent negative earnings announcements. The market capitalisation grade is rated at 3, indicating a relatively modest size within its sector.

The stock’s recent performance has been characterised by consistent declines, with a four-day losing streak culminating in the new 52-week low. This trend is compounded by the stock’s underperformance relative to the Pharmaceuticals & Biotechnology sector, where it lagged by 1.03% on the day of the new low.

Comparative Valuation and Peer Analysis

Despite the negative earnings and price performance, Hikal Ltd’s valuation metrics suggest it is trading at a discount relative to its peers’ historical averages. The enterprise value to capital employed ratio of 1.7 is considered attractive in the context of the sector, potentially reflecting market caution given the company’s recent results and financial ratios.

However, the company’s profitability metrics remain subdued, with an ROCE of 4.1% and a return on equity averaging 8.00%, both below typical sector benchmarks. The stock’s decline of 46.18% over the past year is accompanied by an 86.2% fall in profits, highlighting the scale of the challenges faced.

Shareholding and Sector Position

Hikal Ltd operates within the Pharmaceuticals & Biotechnology industry and sector, where it faces competitive pressures and sector-specific dynamics. The majority shareholding is held by promoters, indicating concentrated ownership. The company’s market cap grade of 3 reflects its mid-tier status within the sector.

Summary of Key Metrics

To summarise, Hikal Ltd’s stock has reached a 52-week low of Rs.197.15 after a sustained period of price decline and underperformance relative to both the sector and broader market indices. The company’s financial results have shown significant contraction in sales and profitability, with negative earnings reported for two consecutive quarters. Key ratios such as ROCE, ROE, and debt-to-EBITDA highlight ongoing financial pressures, while valuation metrics suggest the stock is trading at a discount compared to peers.

The stock’s recent downgrade to a Strong Sell rating by MarketsMOJO reflects these factors, underscoring the challenges faced by the company in maintaining earnings growth and market confidence.

Unlock special upgrade rates for a limited period. Start Saving Now →